Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. - Wikidata - awgldk - TriplyDB

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

http://www.wikidata.org/entity/Q38209927

about

ClC-1 chloride channels: state-of-the-art research and future challenges.Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.Effect on lung function of mounthpiece ventilation in Steinert disease. A case report.In vivo assessment of muscle membrane properties in myotonic dystrophy.Surgical Orthodontic Treatment of a Patient Affected by Type 1 Myotonic Dystrophy (Steinert Syndrome).Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.Core Clinical Phenotypes in Myotonic Dystrophies.

P2860

Q35541006-17F6CAB3-2715-4478-9DCA-9580A92B4584 Q36335776-5571580C-A6FE-4EE7-852F-403F510121FF Q37459974-64DA06F4-997B-4B0C-9CD2-DCA758425ED0 Q37529679-03EC39F9-2803-492C-B7F3-F90EC7F76F93 Q38632916-76E60700-FF3B-4B8B-AB53-A3C59807ED00 Q38812196-ACE67D15-3ED7-4D52-93F2-914F87B9F14C Q41078186-7349CFA8-0437-47BF-BC06-62DF8BF3B058 Q41878069-8A5DF7B8-EBF4-4B9B-A480-5BB0398DD331 Q42204225-B4E030B8-81D9-49A6-8C19-397CCF7F1952 Q50006110-2758FE12-7482-4451-A6A8-99BD48E85550 Q54982478-15D745A0-8D05-4A57-ADA7-5C0FDD68A461 Q55189250-C8E0A6A6-A72D-4286-AA60-440F8EDB44F7

P2860

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

http://www.wikidata.org/entity/Q38209927

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

@en

type

label

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

@en

prefLabel

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

@en

P1433

Q38209927-EFB4B1B9-4B12-4CBE-B607-FE93F55C0CBD

P1476

Q38209927-BACF39B4-6E8D-4328-BBD6-9B42D7DA1714

P2093

Q38209927-1D09337B-A97E-4226-829F-94D807E5F357

P275

Q38209927-96FDDB4A-5EB8-47C5-8441-F9130F533B30

P2860

Q38209927-006B472E-DE4E-4C18-ACE8-09754945F002

Q38209927-0307F0A6-54F3-45BC-8EA7-1A9CB253B12B

Q38209927-05BD7384-14D1-4C48-9072-40CBF8134A3D

Q38209927-05DAF0E7-8DBF-4F98-A7C6-B2E1407196EE

Q38209927-08E65C8B-F784-4E78-873F-C30F30671CF2

Q38209927-0B9EC9D8-0A1F-4A00-9630-CDB334349B5E

Q38209927-1081022F-32BF-4CAB-A326-3922F6A8B024

Q38209927-133F3953-6BC5-43A3-847E-2905DBE3259D

Q38209927-20255ABE-87D3-49E1-B4A3-F64C1B6B26EE

Q38209927-22875C6A-AD92-4456-A893-EA1731ABFC6D

P304

Q38209927-CE67E986-51EF-4F6C-A504-CEF004025939

P31

Q38209927-AC8C8866-A13A-4B60-932D-6D30E66C0F98

Q38209927-C48A8726-E34E-4EB2-8FE4-EFD4D50CF2C9

P433

Q38209927-710919FE-D2EF-437F-BBB7-CDB052224DB2

P478

Q38209927-E3C1FFB9-8658-4D03-A56E-C9A0EE2AB50A

P50

Q38209927-81E0172C-9AC9-42FD-8654-E527D0A43F52

P5008

Q38209927-70BE1A96-196F-4CFE-A288-5291F4AAAEBE

P577

Q38209927-57A54971-3763-4B4F-A7AA-E706FEDCE420

P698

Q38209927-A55E6759-CC77-4FD6-8D58-5676B94482A4

P921

Q38209927-3A5E223C-8842-4686-A127-3A6E3269DE73

Q38209927-9A9C19B4-BFB4-4AEE-8A43-9B4931542664

P932

Q38209927-4671379C-28F3-4534-B0E2-BB05DA8C082A

P1433

P1476

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

@en

P2093

Giovanni Meola

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9

Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum

140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene

Deregulated microRNAs in myotonic dystrophy type 2

Incorrect diagnosis of myotonic dystrophy and its potential consequences revealed by subsequent direct genetic analysis.

High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany.

Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.

P304

154-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24803843

http://www.w3.org/2001/XMLSchema#string

P921

myotonic dystrophy type 2

myotonic dystrophy

P932

4006279

http://www.w3.org/2001/XMLSchema#string